AMRX Amneal Pharmaceuticals, Inc.

NASDAQ

$20.07

Amneal Pharmaceuticals, Inc. (AMRX) Earnings News

Earnings press releases, previews and reviews for Amneal Pharmaceuticals, Inc. (AMRX), newest first.

Thursday July 30, 2026 6:00 AM ET

Amneal Reports Second Quarter 2026 Financial Results

Thursday July 9, 2026 4:05 PM ET

Amneal to Report Second Quarter 2026 Results on July 30, 2026

Thursday May 7, 2026 4:01 PM ET

Amneal Reports First Quarter 2026 Financial Results

Wednesday April 22, 2026 6:00 AM ET

Amneal Agrees to Acquire Kashiv BioSciences to Create Global Biosimilar Leader; Reports Strong Preliminary First Quarter 2026 Financial Results and Raises FY2026 Standalone Guidance

Tuesday April 7, 2026 4:01 PM ET

Amneal to Report First Quarter 2026 Results on May 1, 2026